Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2024-03-22 00:00:00 ET · period of report 2024-03-20 · accession 0001104659-24-037934 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-22 | 2024-03-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | S - Sale+OE | $35.31 | -400 | 8,570 | -4% | -$14.1K |
| D | 2024-03-22 | 2024-03-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $25.30 | +400 | 8,970 | +5% | +$10.1K |
| D | 2024-03-22 | 2024-03-20 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | -400 | 27.2K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-20 | S | D | 400 | $35.31 | 8,570 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-20 | M | A | 400 | $25.30 | 8,970 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-20 | M | D | 400 | $0.00 | 27,236 | D | $25.30 · — to 2027-02-24 | 400 Common Stock | (F2) The option vested in four equal annual installments beginning on February 24, 2018. |